SALT LAKE CITY--(BUSINESS WIRE)--Co-hosts BioUtah and the Office of Technology & Venture Commercialization (TVC) at the University of Utah today announced that registration is open for the Entrepreneur & Investor Life Sciences Summit 2018, to be held March 1-3.
The Entrepreneur and Investor (E&I) Summit is a not-to-be-missed signature conference that connects Utah's entrepreneurs with leading local and national investors in the life sciences. There is no better way for startups and emerging growth companies to gain insights from and broad exposure to some of the best life science corporations, venture capital firms, and angel investors in the business. This exceptional three-day event includes an investor dinner on Thursday, March 1, from 6-8 p.m. at the Natural History Museum; the Summit meeting on Friday, March 2, from 8 a.m.-3:30 p.m. at the Rice-Eccles Stadium; and a Life Science Ski Day at the Park City Mountain Resort on March 3 from 9 a.m.-4 p.m., with lunch at noon. Register now for each day separately at www.bioutah.org/ei-summit-2018.
The E&I Summit will host a distinguished group of speakers and panelists, including industry leaders and national and local investors. The dinner will include high-level networking opportunities with key national and local investors and entrepreneurs. The Summit will facilitate relationships between the investment community and life science entrepreneurs. Highlights include Morning Keynote Speaker Jonathan Norris, Silicon Valley Bank, San Francisco, California, speaking on the State of Life Sciences Investing, company pitches, and reverse pitches. The ski day will provide additional networking opportunities in a relaxed atmosphere.
“The E&I Summit is becoming a premier life science event in the Mountain West region. It’s been a great venue to learn of the continued progress Utah is making in establishing itself as an ideal place to create life science businesses,” explained Mike Grey, Venture Partner at Pappas Ventures.
“Investors are starting to take notice of the life science ecosystem and entrepreneurial culture here in Utah. Recursion Pharmaceuticals has benefited immensely from being part of this community, and we look forward to our ongoing involvement with the E&I Summit,” states entrepreneur Chris Gibson, Ph.D., the Co-Founder and CEO of Recursion Pharmaceuticals, a biotech company leveraging the latest in automation, computation and biology to do drug discovery at scale.
BioUtah is an independent, nonprofit 501(c)(6) trade association serving the life science community in the state of Utah. We are composed of individuals, public and private organizations, and state and academic institutions focused on improving health and wellness through the delivery of innovative technologies and services. Together we create an ecosystem that fosters collaboration, promotes innovation, and accelerates healthcare advances.
We are passionately focused on advancing and growing Utah’s life science industry by promoting new legislative initiatives and fostering the development of robust regional research, development, manufacturing, and testing capabilities along with a full spectrum of commercialization support resources.
Utah’s life science industry is a key driver of Utah’s economic development, representing a significant portion of the state’s economy. BioUtah is committed to growing Utah into a global leader in the life science sector in order to improve healthcare delivery and promote job creation and economic development.
University of Utah is committed to commercializing new technologies and inventions from discoveries made and developed at the U. As a recognized leader, Technology & Venture Commercialization (TVC) manages the university’s intellectual property portfolio, which includes managing invention disclosures, patent prosecution, licensing technologies and spinning out companies based on university inventions. Its purpose is to transform University of Utah discoveries into practical applications. Since 1970, TVC has spun out over 270 companies, including NPS Pharmaceuticals, BioFire, Myriad Genetics, Evans and Sutherland, and Recursion Pharmaceuticals. In 2017, The Milken Institute ranked TVC #1 as Best for Technology Transfer Operation among U.S. universities.